


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
NBIX
Neurocrine Biosciences
$144.17
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Chart
$137.35 (+4.97%)
$132.9 (+8.48%)
$127.31 (+13.24%)
$125 (+15.34%)
NBIX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

NBIX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
NBIX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NBIX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is NBIX current stock price?
What are NBIX stock strengths?
What risks are associated with NBIX stock?
When is NBIX next earnings report?
What is NBIX market cap and volume?
What is NBIX's current Stock IQ?
Should I buy NBIX stock right now?
Is NBIX a Strong Buy right now?
What does a 'Strong Buy' rating mean for NBIX?
What does a 'Strong Sell' rating mean for NBIX?
What factors influence NBIX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
NBIX
Neurocrine Biosciences
Current Price
$144.17
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Chart
$137.35 (+4.97%)
$132.9 (+8.48%)
$127.31 (+13.24%)
$125 (+15.34%)
NBIX Analysts Opinion
NBIX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
NBIX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NBIX Street Sentiment is extremely bullish and have positive views on the near-term outlook
NBIX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
NBIX Latest Analysis
Morgan Stanley Maintains Neurocrine Biosciences (NBIX) Overweight Recommendation. Fintel reports that on November 11 2025 Morgan Stanley maintained coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Overweight recommendation. Analyst Price Forecast Suggests 17.08% Upside
Wed Nov 12, 2025
Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice . Neurocrine (NBIX) possesses solid growth attributes which could help it handily outperform the market.
Tue Nov 11, 2025
Neurocrine Biosciences fails mid-stage study of depression drug.
Mon Nov 10, 2025
Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain?. Neurocrine Biosciences (NBIX) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.
Thu Nov 6, 2025
What Makes Neurocrine (NBIX) a New Strong Buy Stock. Neurocrine (NBIX) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Tue Nov 4, 2025
JP Morgan Maintains Neurocrine Biosciences (NBIX) Overweight Recommendation. Fintel reports that on November 3 2025 JP Morgan maintained coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Overweight recommendation. Analyst Price Forecast Suggests 21.47% Upside
Tue Nov 4, 2025
Truist Securities Reiterates Neurocrine Biosciences (NBIX) Buy Recommendation. Fintel reports that on October 30 2025 Truist Securities reiterated coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Buy recommendation. Analyst Price Forecast Suggests 24.98% Upside
Fri Oct 31, 2025
Canaccord Genuity Maintains Neurocrine Biosciences (NBIX) Buy Recommendation. Fintel reports that on October 29 2025 Canaccord Genuity maintained coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Buy recommendation. Analyst Price Forecast Suggests 24.94% Upside
Thu Oct 30, 2025
Citigroup Maintains Neurocrine Biosciences (NBIX) Buy Recommendation. Fintel reports that on October 29 2025 Citigroup maintained coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Buy recommendation. Analyst Price Forecast Suggests 24.86% Upside
Thu Oct 30, 2025
Piper Sandler Maintains Neurocrine Biosciences (NBIX) Overweight Recommendation. Fintel reports that on October 29 2025 Piper Sandler maintained coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Overweight recommendation. Analyst Price Forecast Suggests 24.86% Upside
Thu Oct 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NBIX Stock trends
NBIX Stock performance
NBIX Stock analysis
NBIX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.